Oncology Letters · 2015 · 37 citations · 16 references
MedicineOncologySurgeryMetastasisNeuro-oncologySurgical OncologyCentral Nervous System TumorsMalignant NeoplasmsMalignant TumorsNeuro-oncologic PathologyPeripheral Nerve TumorsHazard Ratio ModelingMale-to-female RatioMedian AgeNeurofibromatosis Type 1Neurofibromatosis Type 2-Associated TumorsNeurofibromatosis-associated TumorsPrognostic Factors Analysis
Malignant triton tumor (MTT) is a malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation. The prognosis of patients is poor, and due to its rarity, large case studies are lacking. The aim of this study is to describe the clinical features and identify potential prognostic factors. Two patients with MTT in the head and neck treated at our department are reported. A literature search revealed another 198 published cases. All of these cases then went through a retrospective analysis. The ratio of male-to-female incidence was 1.5:1, and the median age at diagnosis was 29 years. In 41.7% of cases it occurred in patients with neurofibromatosis type 1. The five-year survival of MTT was found to be just 35%. Cox proportional hazards analysis revealed that complete resection (hazard ratio, 0.396; P=0.032) and metastases (hazard ratio, 3.188; P=0.004) were associated with mortality, indicating that complete resection may lead to a longer life span, and that the existence of metastasis suggested a worse prognosis for patients with MTT.
16
Peripheral nerve tumors with rhabdomyosarcomatous differentiation (malignant “triton” tumors)
James M. Woodruff, Norman L. Chernik, Myron C. Smith et al. · Cancer · 1973 · 360 citations · Full text
Soft‐tissue sarcomas in children and adolescents with neurofibromatosis type 1
Andrea Ferrari, Gianni Bisogno, Alessandra Macaluso et al. · Cancer · 2007 · 130 citations · Full text
Medicine, Oncology, Pediatrics +17
Malignant triton tumor of the acoustic nerve
Dae Hee Han, Dong Gyu Kim, Je G. et al. · Journal of neurosurgery · 1992 · 79 citations
Medicine, Neurosurgery, Oncology +14